SRC AND RAS PROTO-ONCOGENES AND NGF-INDUCED EVENTS
SRC AND RAS PROTO-ONCOGENES AND NGF-INDUCED EVENTS
批准号:
2092645
负责人:
Joan Siefert Brugge
金额:
$19.17万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-04-01 至 1998-04-30
关键词:
PC12 cells biological signal transduction cell cycle proteins developmental genetics developmental neurobiology enzyme induction /repression gene expression growth factor receptors guanine nucleotide binding protein neurogenesis neurotrophic factors protein purification protein structure function protein tyrosine kinase protooncogene receptor binding
中文摘要
PC12细胞为研究信号提供了一个有用的模型系统
神经生长因子诱导的信号转导通路
神经元分化。早期的研究表明src和ras相关。
原癌基因家族在神经生长因子刺激的轴突中的关键作用
在PC12细胞中生长。这些项目的主要目标之一是
本申请中提出的是定义Src和RAS家族的角色
调节NGF诱导的轴突形成的早期信号事件中的蛋白质
外延生长。我们将重点关注NGF诱导的三个具体方面
信号转导:i)激活Src家族的激酶,它们与
NGF受体及其在NGF诱导的轴突生长中的作用,2)作用
Shc和Grb2/Sem5在RAS激活中的作用及其调控途径
RAS,以及3)识别参与
MAP激酶和其他细胞事件的激活。初级阶段
这些项目所涉及的策略涉及使用
允许可诱导表达高水平的结构性激活或
显性干扰分子Src、Ras、Shc、Grb2、GAP和Raf,以及
使用亲和纯化策略来识别之前
这些通路的不明成分。另外,还有一秒钟
目标是确定特定相互作用的细胞蛋白质
在Src+的SH3结构域中,Src的变体形式是
在神经元中表达。后一项研究的目标是理解
六个氨基酸是如何插入到该蛋白质的SH3结构域中的
调节其在神经元中的功能活动。
英文摘要
PC12 cells have provided a useful model system to investigate signal
transduction pathways involved in nerve growth factor (NGF)-induced
neuronal differentiation. Earlier studies have implicated src- and ras
family proto-oncogenes as critical components in NGF-stimulated neurite
outgrowth in PC12 cells. One of the major objectives of the projects
proposed in this application is to define role of Src- and Ras-family
proteins in the early signaling events that regulate NGF-induced neurite
outgrowth. We will focus on three specific aspects of NGF-induced
signaling: i) the activation of Src family kinases, their binding to the
NGF receptor, and their role in NGF-induced neurite outgrowth, 2) the role
of Shc and Grb2/Sem5 in the activation of Ras and pathways regulated by
Ras, and 3) the identification of Ras targets that are involved in the
activation of MAP kinases and other cellular events. The primary
strategies involved in these projects involve the use of vectors that
allow inducible expression of high levels of constitutively activated or
dominant-interfering molecules of Src, Ras, Shc, Grb2, GAP, and Raf, and
the use of affinity purification strategies to identify previously
unidentified components of these pathways. In addition, a second
objective, is to identify cellular proteins that specifically interact
with the SH3 domain of Src+, the variant form of Src that is specifically
expressed in neurons. The goal of these latter studies is to understand
how the six amino acid insert within the SH3 domain of this protein
regulates its functional activity in neurons.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
-
批准号:10683138
-
项目类别:
-
资助金额:$99.67万
-
财政年份:2019
-
负责人:Joan Siefert Brugge
-
依托单位:
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
-
批准号:10817308
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2019
-
负责人:Joan Siefert Brugge
-
依托单位:
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
-
批准号:10001481
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2019
-
负责人:Joan Siefert Brugge
-
依托单位:
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
-
批准号:10472573
-
项目类别:
-
资助金额:$99.67万
-
财政年份:2019
-
负责人:Joan Siefert Brugge
-
依托单位:
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
-
批准号:10249258
-
项目类别:
-
资助金额:$85.16万
-
财政年份:2019
-
负责人:Joan Siefert Brugge
-
依托单位:
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
-
批准号:9816264
-
项目类别:
-
资助金额:$101.7万
-
财政年份:2019
-
负责人:Joan Siefert Brugge
-
依托单位:
Breast Tumor Heterogeneity and its Impact on Tumor Progression
-
批准号:8633707
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2014
-
负责人:Joan Siefert Brugge
-
依托单位:
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
-
批准号:8839745
-
项目类别:
-
资助金额:$39.79万
-
财政年份:2014
-
负责人:Joan Siefert Brugge
-
依托单位:
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
-
批准号:8613292
-
项目类别:
-
资助金额:$39.82万
-
财政年份:2014
-
负责人:Joan Siefert Brugge
-
依托单位:
Analysis of Intratumoral Crosstalk in Clonal Populations of OvarianTumor Cells
-
批准号:9025763
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2014
-
负责人:Joan Siefert Brugge
-
依托单位:
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
-
批准号:8215975
-
项目类别:
-
资助金额:$36.85万
-
财政年份:2011
-
负责人:Joan Siefert Brugge
-
依托单位:
Use of Organotypic and Mammary Gland Models to Investigate the Outcomes of Clonal
-
批准号:7617421
-
项目类别:
-
资助金额:$38.44万
-
财政年份:2009
-
负责人:Joan Siefert Brugge
-
依托单位:
Variation in Receptor Tyrosine Kinases and Breast Cancer Risk
-
批准号:7729488
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2008
-
负责人:Joan Siefert Brugge
-
依托单位:
Discovery
-
批准号:7195621
-
项目类别:
-
资助金额:$14.59万
-
财政年份:2006
-
负责人:Joan Siefert Brugge
-
依托单位:
P-6: Variation in Receptor Tyrosine Kinases and Breast Cancer Risk
-
批准号:6966199
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2005
-
负责人:Joan Siefert Brugge
-
依托单位:
Mechanisms Involved in Mammary Morphogenesis
-
批准号:6989354
-
项目类别:
-
资助金额:$14.87万
-
财政年份:2004
-
负责人:Joan Siefert Brugge
-
依托单位:
Cell Death Regulation in Lumen Formation and Oncogenesis
-
批准号:7368284
-
项目类别:
-
资助金额:$48.17万
-
财政年份:2003
-
负责人:Joan Siefert Brugge
-
依托单位:
Cell Death Regulation in Lumen Formation and Oncogenesis
-
批准号:7895915
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2003
-
负责人:Joan Siefert Brugge
-
依托单位:
Cell Death Regulation in Lumen Formation and Oncogenesis
-
批准号:6719923
-
项目类别:
-
资助金额:$37.44万
-
财政年份:2003
-
负责人:Joan Siefert Brugge
-
依托单位:
Cell Death Regulation in Lumen Formation and Oncogenesis
-
批准号:6933879
-
项目类别:
-
资助金额:$37.71万
-
财政年份:2003
-
负责人:Joan Siefert Brugge
-
依托单位:
海外基金